Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1214-1224, July 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pollak, R. D.
Right arrow Articles by Rosenkranz, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pollak, R. D.
Right arrow Articles by Rosenkranz, H. S.

Metabolic Effects of Hydroxyurea on BHK-21 Cells Transformed with Polyoma Virus1

Richard D. Pollak and Herbert S. Rosenkranz2

Department of Microbiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032

Hydroxyurea interferes with the DNA metabolism of BHK-21 cells transformed by polyoma virus. The syntheses of RNA and proteins are not affected by concentrations of the drug which completely abolish DNA production. Evidence is presented which indicates that the metabolic block in DNA synthesis is not at the enzymic reduction of ribonucleotides to the corresponding deoxyribonucleotides. In BHK-21 cells, hydroxyurethan appears to have an effect similar to that of hydroxyurea. Hydroxylamine on the other hand was not found to be a specific inhibitor of DNA synthesis.

1 This is the fourth paper in a series dealing with hydroxyurea. Paper III described the abnormal DNA isolated from hydroxyurea-treated bacteria (40). This investigation was aided by the Dr. George A. Carden, Jr., Special Fund for Cancer Research. Support was also provided by a USPHS Research Grant No. CA-08374 from the National Cancer Institute as well as by a contract [Nonr266(89)-NR 103–574] between the Office of Naval Research, Department of the Navy, and Columbia University.

2 Research Career Development Awardee of the National Institute of General Medical Sciences, USPHS (5-K3-GM-29,024).

Received 10/20/66. Accepted 3/ 7/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.